Daily as of 3 Nov 16:00 ET
- Price
- above both $25.15 vs 50 $21.70 / 200 $21.68
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 22 Apr 2026 · projected 21 bars out
VRDN | Viridian TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$25.15
-$0.15 (-0.59%)
Viridian Therapeutics (VRDN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
The 50 SMA has sat above the 200 on the daily since Nov 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $24.67 vs 50 $23.35 / 200 $20.46
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 12 Jan 2026 · projected 30 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $25.15 vs 50 $21.10 / 200 $20.79
- Projection
- No cross projected
- Test
- Cross test window open, no test bar yet
- Last cross
- 🟨Golden cross 29 Oct 2026 · projected 20 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 29 Oct 2026 | 🟨Golden | 4-hour | 20 bars out | Active Cross Test |
| 21 Oct 2026 | 💀Death | 4-hour | 30 bars out | Not tested |
| 28 Jul 2026 | 🟨Golden | 4-hour | 26 bars out | 3 bar cross test |
| 22 Apr 2026 | 💀Death steep | daily | 21 bars out | Not tested |
| 10 Mar 2026 | 💀Death | 4-hour | 30 bars out | 3 bar cross test |
About VRDN
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$35.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandmid